title: Remifentanil in the intensive care unit: tolerance and acute withdrawal syndrome after prolonged sedation.
authors.affiliation: Anesthesiology Department, University Hospital Saint-Luc, Catholic University of Louvain, Avenue Hippocrate 10, B-1200 Brussels, Belgium. delvauxbernard@yahoo.fr
authors.forename: Bernard
authors.initials: B
authors.lastname: Delvaux
authors.forename: Yves
authors.initials: Y
authors.lastname: Ryckwaert
authors.forename: Michel
authors.initials: M
authors.lastname: Van Boven
authors.forename: Marc
authors.initials: M
authors.lastname: De Kock
authors.forename: Xavier
authors.initials: X
authors.lastname: Capdevila
mesh_terms: D000328:Adult; D000368:Aged; D016292:Procedural Sedation / Q000009:adverse effects / Q000379:methods; D004361:Drug Tolerance / Q000502:physiology; D005260:Female; D006801:Humans; D006993:Hypnotics and Sedatives / Q000009:adverse effects*; D007362:Intensive Care Units; D008297:Male; D010880:Piperidines / Q000009:adverse effects*; D000077208:Remifentanil; D013375:Substance Withdrawal Syndrome / Q000175:diagnosis*; D013997:Time Factors
chemical_list: D006993:Hypnotics and Sedatives; D010880:Piperidines; D000077208:Remifentanil